logo
logo

Alterome Therapeutics Launches With $64M Series A Financing

Jan 19, 2022•over 3 years ago

Amount Raised

$64 Million

Round Type

series a

San Diego

Description

Alterome Therapeutics, Inc., a biopharmaceutical company developing alteration-specific targeted therapies for the treatment of cancer, announced the closing of a $64M Series A financing. The financing was led by OrbiMed, with participation from Nextech Invest, Vida Ventures, Boxer Capital, and others. Alterome Therapeutics was co-founded by Eric Murphy, Ph.D., and Ryan Corcoran, M.D., Ph.D.

Company Information

Company

Alterome Therapeutics

Location

San Diego, California, United States

About

Alterome Therapeutics, Inc. is a precision oncology biotech developing alteration-specific therapeutics to address high value and validated oncogenic drivers. The company will be led by seasoned R&D leaders with a history of developing marketed oncology small molecule drugs.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech